An Unusual Dimeric Inhibitor of Acetylcholinesterase: Cooperative Binding of Crystal Violet

Acetylcholinesterase (AChE) is an essential enzyme that terminates cholinergic transmission by a rapid hydrolysis of the neurotransmitter acetylcholine. AChE is an important target for treatment of various cholinergic deficiencies, including Alzheimer’s disease and myasthenia gravis. In a previous h...

Full description

Bibliographic Details
Main Authors: Anders Allgardsson, C. David Andersson, Christine Akfur, Franz Worek, Anna Linusson, Fredrik Ekström
Format: Article
Language:English
Published: MDPI AG 2017-08-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/22/9/1433
id doaj-1e9683bc80cc43f3a31ebf401b9f79d2
record_format Article
spelling doaj-1e9683bc80cc43f3a31ebf401b9f79d22020-11-25T01:02:12ZengMDPI AGMolecules1420-30492017-08-01229143310.3390/molecules22091433molecules22091433An Unusual Dimeric Inhibitor of Acetylcholinesterase: Cooperative Binding of Crystal VioletAnders Allgardsson0C. David Andersson1Christine Akfur2Franz Worek3Anna Linusson4Fredrik Ekström5Swedish Defence Research Agency, SE-90281 Umeå, SwedenDepartment of Chemistry, Umeå University, SE-90187 Umeå, SwedenSwedish Defence Research Agency, SE-90281 Umeå, SwedenDepartment of Toxicological Enzymology, Bundeswehr Institute of Pharmacology and Toxicology, 80937 Munich, GermanyDepartment of Chemistry, Umeå University, SE-90187 Umeå, SwedenSwedish Defence Research Agency, SE-90281 Umeå, SwedenAcetylcholinesterase (AChE) is an essential enzyme that terminates cholinergic transmission by a rapid hydrolysis of the neurotransmitter acetylcholine. AChE is an important target for treatment of various cholinergic deficiencies, including Alzheimer’s disease and myasthenia gravis. In a previous high throughput screening campaign, we identified the dye crystal violet (CV) as an inhibitor of AChE. Herein, we show that CV displays a significant cooperativity for binding to AChE, and the molecular basis for this observation has been investigated by X-ray crystallography. Two monomers of CV bind to residues at the entrance of the active site gorge of the enzyme. Notably, the two CV molecules have extensive intermolecular contacts with each other and with AChE. Computational analyses show that the observed CV dimer is not stable in solution, suggesting the sequential binding of two monomers. Guided by the structural analysis, we designed a set of single site substitutions, and investigated their effect on the binding of CV. Only moderate effects on the binding and the cooperativity were observed, suggesting a robustness in the interaction between CV and AChE. Taken together, we propose that the dimeric cooperative binding is due to a rare combination of chemical and structural properties of both CV and the AChE molecule itself.https://www.mdpi.com/1420-3049/22/9/1433cholinesteraseacetylcholinesterasecooperativitycrystal violetHill coefficientnew modalitynon-bonded bivalence
collection DOAJ
language English
format Article
sources DOAJ
author Anders Allgardsson
C. David Andersson
Christine Akfur
Franz Worek
Anna Linusson
Fredrik Ekström
spellingShingle Anders Allgardsson
C. David Andersson
Christine Akfur
Franz Worek
Anna Linusson
Fredrik Ekström
An Unusual Dimeric Inhibitor of Acetylcholinesterase: Cooperative Binding of Crystal Violet
Molecules
cholinesterase
acetylcholinesterase
cooperativity
crystal violet
Hill coefficient
new modality
non-bonded bivalence
author_facet Anders Allgardsson
C. David Andersson
Christine Akfur
Franz Worek
Anna Linusson
Fredrik Ekström
author_sort Anders Allgardsson
title An Unusual Dimeric Inhibitor of Acetylcholinesterase: Cooperative Binding of Crystal Violet
title_short An Unusual Dimeric Inhibitor of Acetylcholinesterase: Cooperative Binding of Crystal Violet
title_full An Unusual Dimeric Inhibitor of Acetylcholinesterase: Cooperative Binding of Crystal Violet
title_fullStr An Unusual Dimeric Inhibitor of Acetylcholinesterase: Cooperative Binding of Crystal Violet
title_full_unstemmed An Unusual Dimeric Inhibitor of Acetylcholinesterase: Cooperative Binding of Crystal Violet
title_sort unusual dimeric inhibitor of acetylcholinesterase: cooperative binding of crystal violet
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2017-08-01
description Acetylcholinesterase (AChE) is an essential enzyme that terminates cholinergic transmission by a rapid hydrolysis of the neurotransmitter acetylcholine. AChE is an important target for treatment of various cholinergic deficiencies, including Alzheimer’s disease and myasthenia gravis. In a previous high throughput screening campaign, we identified the dye crystal violet (CV) as an inhibitor of AChE. Herein, we show that CV displays a significant cooperativity for binding to AChE, and the molecular basis for this observation has been investigated by X-ray crystallography. Two monomers of CV bind to residues at the entrance of the active site gorge of the enzyme. Notably, the two CV molecules have extensive intermolecular contacts with each other and with AChE. Computational analyses show that the observed CV dimer is not stable in solution, suggesting the sequential binding of two monomers. Guided by the structural analysis, we designed a set of single site substitutions, and investigated their effect on the binding of CV. Only moderate effects on the binding and the cooperativity were observed, suggesting a robustness in the interaction between CV and AChE. Taken together, we propose that the dimeric cooperative binding is due to a rare combination of chemical and structural properties of both CV and the AChE molecule itself.
topic cholinesterase
acetylcholinesterase
cooperativity
crystal violet
Hill coefficient
new modality
non-bonded bivalence
url https://www.mdpi.com/1420-3049/22/9/1433
work_keys_str_mv AT andersallgardsson anunusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet
AT cdavidandersson anunusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet
AT christineakfur anunusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet
AT franzworek anunusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet
AT annalinusson anunusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet
AT fredrikekstrom anunusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet
AT andersallgardsson unusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet
AT cdavidandersson unusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet
AT christineakfur unusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet
AT franzworek unusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet
AT annalinusson unusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet
AT fredrikekstrom unusualdimericinhibitorofacetylcholinesterasecooperativebindingofcrystalviolet
_version_ 1725206090997563392